Methotrexate vs Mirvetuximab Soravtansine

## Methotrexate vs Mirvetuximab Soravtansine: Overview

This comparison examines the pharmacological differences between **Methotrexate** and **Mirvetuximab Soravtansine**.

## Mechanism of Action

**Methotrexate**: Dihydrofolate reductase inhibitor.

## Pharmacokinetics

**Half-life**: Methotrexate — 3-10 hours; Mirvetuximab Soravtansine — N/A.

## Chemical Properties

**Molecular Formula**: Methotrexate — C20H22N8O5; Mirvetuximab Soravtansine — N/A.

**Molecular Weight**: Methotrexate — 454.4400 g/mol; Mirvetuximab Soravtansine — N/A.

**Type**: Methotrexate — Small molecule; Mirvetuximab Soravtansine — Antibody drug conjugate.